INGRAM DOUGLAS S 4
4 · Sarepta Therapeutics, Inc. · Filed Jan 3, 2020
Insider Transaction Report
Form 4
INGRAM DOUGLAS S
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2019-12-31$129.04/sh−37,185$4,798,352→ 395,012 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.